Datawatch (DWCH) Reaches $10.43 After 8.00% Up Move, APPLIED GENETIC TECHNOLOGIES (AGTC) Has 1.26 Sentiment

July 20, 2017 - By Hazel Jackson

The stock of Datawatch Corporation (NASDAQ:DWCH) is a huge mover today! About 425,302 shares traded or 206.06% up from the average. Datawatch Corporation (NASDAQ:DWCH) has risen 56.31% since July 20, 2016 and is uptrending. It has outperformed by 39.61% the S&P500.The move comes after 8 months positive chart setup for the $128.05M company. It was reported on Jul, 20 by Barchart.com. We have $11.26 PT which if reached, will make NASDAQ:DWCH worth $10.24M more.

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The company has market cap of $92.37 million. The Firm develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. It has a 11.67 P/E ratio. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis , over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP).

Datawatch Corporation is engaged in the design, development, marketing, distribution and support of business computer software primarily for the self-service data preparation and visual data discovery markets. The company has market cap of $128.05 million. The Firm also provides services, including implementation and support of its software products, as well as training on their use and administration. It currently has negative earnings. The Company’s product family includes Datawatch Monarch, Datawatch Panopticon and Datawatch Report Mining Server .

Among 2 analysts covering Datawatch Corporation (NASDAQ:DWCH), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Datawatch Corporation has $1000 highest and $5.75 lowest target. $7.88’s average target is -24.45% below currents $10.43 stock price. Datawatch Corporation had 2 analyst reports since November 20, 2015 according to SRatingsIntel. Canaccord Genuity maintained Datawatch Corporation (NASDAQ:DWCH) rating on Wednesday, July 19. Canaccord Genuity has “Hold” rating and $1000 target.

Since January 23, 2017, it had 1 buy, and 4 sales for $919,485 activity. $109,667 worth of Datawatch Corporation (NASDAQ:DWCH) shares were sold by Morrison Michael Anthony. The insider G2 Investment Partners Management LLC bought $56. 8,091 shares valued at $69,016 were sold by Tacelli Ken on Friday, May 5. Seidl Randy also sold $291,923 worth of Datawatch Corporation (NASDAQ:DWCH) on Monday, January 30.

Investors sentiment increased to 3.29 in 2016 Q4. Its up 2.56, from 0.73 in 2016Q3. It is positive, as 5 investors sold Datawatch Corporation shares while 2 reduced holdings. 14 funds opened positions while 9 raised stakes. 9.40 million shares or 220.41% more from 2.93 million shares in 2016Q3 were reported. Morgan Stanley invested 0% of its portfolio in Datawatch Corporation (NASDAQ:DWCH). Ray Gerald L Associates reported 63,426 shares. Renaissance Techs Limited Liability reported 0% stake. California Pub Employees Retirement reported 0% stake. Bank & Trust Of America Corp De accumulated 17,110 shares. Essex Investment Management Limited Liability Company invested in 0.1% or 112,824 shares. Kcg holds 0% or 16,451 shares in its portfolio. Teton Advsr accumulated 30,000 shares. Moreover, Dimensional Fund Advsr Lp has 0% invested in Datawatch Corporation (NASDAQ:DWCH). Kennedy Capital Mgmt Inc has invested 0.01% in Datawatch Corporation (NASDAQ:DWCH). Art Advisors stated it has 0.01% of its portfolio in Datawatch Corporation (NASDAQ:DWCH). G2 Prtnrs Ltd Liability Com holds 4.96% or 1.83 million shares in its portfolio. Vanguard Gp holds 531,191 shares. Millennium Mgmt Ltd Limited Liability Company stated it has 14,491 shares or 0% of all its holdings. Tealwood Asset Management Inc accumulated 21,425 shares.

Dafna Capital Management Llc holds 2.35% of its portfolio in Applied Genetic Technologies Corp for 286,298 shares. Globeflex Capital L P owns 124,514 shares or 0.29% of their US portfolio. Moreover, Eventide Asset Management Llc has 0.17% invested in the company for 279,100 shares. The Pennsylvania-based Emerald Mutual Fund Advisers Trust has invested 0.15% in the stock. Emerald Advisers Inc Pa, a Pennsylvania-based fund reported 283,551 shares.

About 80,549 shares traded. Applied Genetic Technologies Corp (AGTC) has declined 65.28% since July 20, 2016 and is downtrending. It has underperformed by 81.98% the S&P500.